We are live on ! Find out more
FCM

Fourpath Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 29.98%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+29.98%
3 Year Est. Return
+72.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$2.97M
Cap. Flow
-$10.8M
Cap. Flow %
-7.46%
Top 10 Hldgs %
48.25%
Holding
148
New
12
Increased
38
Reduced
78
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$530K
2
FJUL icon
FT Vest US Equity Buffer ETF July
FJUL
+$508K
3
GILD icon
Gilead Sciences
GILD
+$351K
4
TGT icon
Target
TGT
+$267K
5
LLY icon
Eli Lilly
LLY
+$238K

Top Sells

Rank Stock Value
1
RWM icon
ProShares Short Russell2000
RWM
+$3.92M
2
SJB icon
ProShares Short High Yield
SJB
+$2.41M
3
SH icon
ProShares Short S&P500
SH
+$2.23M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$1.35M
5
MDT icon
Medtronic
MDT
+$565K

Sector Composition

Rank Sector Weight
1 Energy 16.92%
2 Technology 8.48%
3 Financials 6.92%
4 Healthcare 6.43%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RSP icon
76
Invesco S&P 500 Equal Weight ETF
RSP
$96.4B
$467K 0.32%
2,756
-54
-2% -$8.67K
IWR icon
77
iShares Russell Mid-Cap ETF
IWR
$56.6B
$465K 0.32%
5,532
– –
SPEM icon
78
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.9B
$442K 0.31%
12,213
-58
-0.5% -$2.04K
IWM icon
79
iShares Russell 2000 ETF
IWM
$82.2B
$441K 0.31%
2,099
– –
NMFC icon
80
New Mountain Finance
NMFC
$672M
$435K 0.3%
34,299
– –
VEA icon
81
Vanguard FTSE Developed Markets ETF
VEA
$226B
$430K 0.3%
8,571
+219
+3% +$10.6K
AMCR icon
82
Amcor
AMCR
$20.3B
$422K 0.29%
8,881
-146
-2% -$6.83K
ACN icon
83
Accenture
ACN
$87.9B
$409K 0.28%
1,181
+11
+0.9% +$4.01K
GBIL icon
84
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.68B
$399K 0.28%
3,959
+1,589
+67% +$159K
XEL icon
85
Xcel Energy
XEL
$49.2B
$399K 0.28%
7,428
-148
-2% -$8.45K
LHX icon
86
L3Harris
LHX
$52.5B
$397K 0.28%
1,861
-20
-1% -$4.2K
PAYX icon
87
Paychex
PAYX
$40.7B
$374K 0.26%
3,045
-91
-3% -$11K
STX icon
88
Seagate
STX
$178B
$345K 0.24%
3,709
-14
-0.4% -$1.23K
GSBD icon
89
Goldman Sachs BDC
GSBD
$994M
$339K 0.24%
22,645
+47
+0.2% +$711
SPGI icon
90
S&P Global
SPGI
$133B
$337K 0.23%
792
-64
-7% -$27.7K
TGT icon
91
Target
TGT
$63.4B
$311K 0.22%
+1,757
New +$267K
TMO icon
92
Thermo Fisher Scientific
TMO
$198B
$310K 0.22%
534
-3
-0.6% -$1.68K
ETN icon
93
Eaton
ETN
$155B
$308K 0.21%
985
-50
-5% -$13.7K
SPTM icon
94
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$307K 0.21%
4,780
-4,532
-49% -$277K
JCI icon
95
Johnson Controls International
JCI
$85.7B
$298K 0.21%
4,563
-41
-0.9% -$2.39K
CRM icon
96
Salesforce
CRM
$140B
$292K 0.2%
970
-20
-2% -$5.77K
FCX icon
97
Freeport-McMoran
FCX
$83.9B
$291K 0.2%
6,193
-52
-0.8% -$2.1K
OKE icon
98
Oneok
OKE
$58.9B
$290K 0.2%
3,622
+5
+0.1% +$365
C icon
99
Citigroup
C
$217B
$280K 0.19%
4,431
+3
+0.1% +$167
VIG icon
100
Vanguard Dividend Appreciation ETF
VIG
$111B
$280K 0.19%
1,531
+2
+0.1% +$351
2 3
4
5 6

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
AIA
Allied Investment Advisors Billings, Montana $697M AUM 21.33% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return

Fourpath Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fourpath Capital Management held 148 positions worth $144M, down 2% from $147M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fourpath Capital Management withdrew a net $10.8M in Q1 2024, closing 8 positions and reducing 78 holdings. Its most notable exit was Medtronic, an estimated $565K position sold in full.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Fourpath Capital Management opened a new position in Bristol-Myers Squibb worth $564K.

  • Fourpath Capital Management's largest Q1 2024 buy was Bristol-Myers Squibb: 10,407 shares worth $564K.
  • Fourpath Capital Management added most to Gilead Sciences in Q1 2024, an estimated $351K increase.
  • Fourpath Capital Management's biggest Q1 2024 reduction was ProShares Short Russell2000, cutting an estimated $3.92M.
  • Fourpath Capital Management fully exited Medtronic in Q1 2024, selling an estimated $565K.
  • Fourpath Capital Management's ten largest holdings make up 48% of its $144M portfolio in Q1 2024.
  • Fourpath Capital Management opened 12 new positions and closed 8 in Q1 2024.
  • Fourpath Capital Management's portfolio value fell 2% quarter-over-quarter to $144M.

Based on Fourpath Capital Management's 13F filing for Q1 2024, filed 7 May 2024.